Medicis Pharmaceuticals (NYSE: MRX), Manning & Napier Inc. (NYSE: MN), Cavium Networks, Inc. (NASDAQ: CAVM), Fortinet, Inc. (NASDAQ: FTNT), Gleacher & Company, Inc. (NASDAQ: GLCH) and Ceva Inc. (NASDAQ: CEVA) ratings and price targets.
Stifel Nicolaus initiated coverage on Manning & Napier Inc. (MN). They placed a “Buy” rating and a price target of $15.00 on the company.
Cavium Networks, Inc. (CAVM) had its “Perform” rating reiterated by Oppenheimer.
Medicis Pharmaceuticals (MRX) had its price target lowered by Goldman Sachs (NYSE:GS) to $38.00.
Fortinet, Inc. (FTNT) was downgraded by Zacks Investment Research from an “Outperform” rating to a “Neutral” rating.
Gleacher & Company, Inc. (GLCH) was downgraded by Zacks Investment Research from a “Neutral” rating to an “Underperform” rating.
Ceva Inc. (CEVA) was upgraded by Zacks Investment Research from a “Neutral” rating to an “Outperform” rating.
Thursday, December 29, 2011
Medicis (MRX) (MN) (CAVM) (FTNT) (GLCH) (CEVA) Ratings, Price Targets
Labels:
Goldman Sachs
Subscribe to:
Post Comments (Atom)
![[Most Recent Quotes from www.kitco.com]](http://www.kitconet.com/charts/metals/gold/t24_au_en_usoz_2.gif)
No comments:
Post a Comment